Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vismodegib for BCC Chemoprevention in High-Risk Subjects
NCT02067104Phase 2Terminated
- Sponsor
- University of Arizona
- Start
- Feb 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vismodegib in basal cell carcinoma (BCC), sponsored by University of Arizona. Started Feb 2014; status: terminated.
02
Drugs
vismodegib
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT02067104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02067104.